pubmed-article:18565233 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:18565233 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:18565233 | lifeskim:mentions | umls-concept:C1956346 | lld:lifeskim |
pubmed-article:18565233 | lifeskim:mentions | umls-concept:C0007102 | lld:lifeskim |
pubmed-article:18565233 | lifeskim:mentions | umls-concept:C0005330 | lld:lifeskim |
pubmed-article:18565233 | lifeskim:mentions | umls-concept:C0166418 | lld:lifeskim |
pubmed-article:18565233 | lifeskim:mentions | umls-concept:C1621296 | lld:lifeskim |
pubmed-article:18565233 | pubmed:dateCreated | 2008-6-26 | lld:pubmed |
pubmed-article:18565233 | pubmed:abstractText | Epidemiologic studies have suggested that hypertriglyceridemia and insulin resistance are related to the development of colon cancer. Nuclear peroxisome proliferator-activated receptors (PPAR), which play a central role in lipid and glucose metabolism, had been hypothesized as being involved in colon cancerogenesis. In animal studies the lipid-lowering PPAR ligand bezafibrate suppressed colonic tumors. However, the effect of bezafibrate on colon cancer development in humans is unknown. Therefore, we proposed to investigate a possible preventive effect of bezafibrate on the development of colon cancer in patients with coronary artery disease during a 6-year follow-up. | lld:pubmed |
pubmed-article:18565233 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18565233 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18565233 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18565233 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18565233 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18565233 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18565233 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18565233 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18565233 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18565233 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18565233 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18565233 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18565233 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18565233 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18565233 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18565233 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18565233 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18565233 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18565233 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18565233 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18565233 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18565233 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18565233 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18565233 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18565233 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18565233 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18565233 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18565233 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18565233 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18565233 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18565233 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18565233 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18565233 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18565233 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18565233 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18565233 | pubmed:language | eng | lld:pubmed |
pubmed-article:18565233 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18565233 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:18565233 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18565233 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18565233 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18565233 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18565233 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:18565233 | pubmed:issn | 1475-2840 | lld:pubmed |
pubmed-article:18565233 | pubmed:author | pubmed-author:TanneDavidD | lld:pubmed |
pubmed-article:18565233 | pubmed:author | pubmed-author:BoykoValentin... | lld:pubmed |
pubmed-article:18565233 | pubmed:author | pubmed-author:AdlerYehudaY | lld:pubmed |
pubmed-article:18565233 | pubmed:author | pubmed-author:BeharSolomonS | lld:pubmed |
pubmed-article:18565233 | pubmed:author | pubmed-author:MotroMichaelM | lld:pubmed |
pubmed-article:18565233 | pubmed:author | pubmed-author:TenenbaumAlex... | lld:pubmed |
pubmed-article:18565233 | pubmed:author | pubmed-author:FismanEnrique... | lld:pubmed |
pubmed-article:18565233 | pubmed:author | pubmed-author:ShemeshJoseph... | lld:pubmed |
pubmed-article:18565233 | pubmed:author | pubmed-author:Schwammenthal... | lld:pubmed |
pubmed-article:18565233 | pubmed:author | pubmed-author:FeinbergMicha... | lld:pubmed |
pubmed-article:18565233 | pubmed:author | pubmed-author:GoldenbergIla... | lld:pubmed |
pubmed-article:18565233 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:18565233 | pubmed:volume | 7 | lld:pubmed |
pubmed-article:18565233 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:18565233 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:18565233 | pubmed:pagination | 18 | lld:pubmed |
pubmed-article:18565233 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
pubmed-article:18565233 | pubmed:meshHeading | pubmed-meshheading:18565233... | lld:pubmed |
pubmed-article:18565233 | pubmed:meshHeading | pubmed-meshheading:18565233... | lld:pubmed |
pubmed-article:18565233 | pubmed:meshHeading | pubmed-meshheading:18565233... | lld:pubmed |
pubmed-article:18565233 | pubmed:meshHeading | pubmed-meshheading:18565233... | lld:pubmed |
pubmed-article:18565233 | pubmed:meshHeading | pubmed-meshheading:18565233... | lld:pubmed |
pubmed-article:18565233 | pubmed:meshHeading | pubmed-meshheading:18565233... | lld:pubmed |
pubmed-article:18565233 | pubmed:meshHeading | pubmed-meshheading:18565233... | lld:pubmed |
pubmed-article:18565233 | pubmed:meshHeading | pubmed-meshheading:18565233... | lld:pubmed |
pubmed-article:18565233 | pubmed:meshHeading | pubmed-meshheading:18565233... | lld:pubmed |
pubmed-article:18565233 | pubmed:meshHeading | pubmed-meshheading:18565233... | lld:pubmed |
pubmed-article:18565233 | pubmed:meshHeading | pubmed-meshheading:18565233... | lld:pubmed |
pubmed-article:18565233 | pubmed:meshHeading | pubmed-meshheading:18565233... | lld:pubmed |
pubmed-article:18565233 | pubmed:meshHeading | pubmed-meshheading:18565233... | lld:pubmed |
pubmed-article:18565233 | pubmed:meshHeading | pubmed-meshheading:18565233... | lld:pubmed |
pubmed-article:18565233 | pubmed:meshHeading | pubmed-meshheading:18565233... | lld:pubmed |
pubmed-article:18565233 | pubmed:meshHeading | pubmed-meshheading:18565233... | lld:pubmed |
pubmed-article:18565233 | pubmed:meshHeading | pubmed-meshheading:18565233... | lld:pubmed |
pubmed-article:18565233 | pubmed:meshHeading | pubmed-meshheading:18565233... | lld:pubmed |
pubmed-article:18565233 | pubmed:year | 2008 | lld:pubmed |
pubmed-article:18565233 | pubmed:articleTitle | Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? | lld:pubmed |
pubmed-article:18565233 | pubmed:affiliation | Cardiac Rehabilitation Institute, Chaim Sheba Medical Center, Tel-Hashomer, affiliated with Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel. altenen@post.tau.ac.il | lld:pubmed |
pubmed-article:18565233 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:18565233 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18565233 | lld:pubmed |